Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter

  • Chung, Han-Hee (Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine) ;
  • Moon, Keon-Woong (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine) ;
  • Jung, Mi-Hyang (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine) ;
  • Yang, Hae-Kyung (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine) ;
  • Park, Kyung-Seon (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine) ;
  • Yoo, Ki-Dong (Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine)
  • Published : 2012.06.30
⟨ Previous Next ⟩

Abstract

Drug-eluting balloon (DEB) with angioplasty a paclitaxel-coated balloon catheter is an effective treatment option in patients with in-stent restenosis (ISR) after a drug-eluting stent (DES). We describe a case in which 'no-reflow' phenomenon developed after DEB angioplasty of a DES ISR lesion. Coronary flow was restored after intracoronary administration of nicorandil.

Keywords

References

  1. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94. https://doi.org/10.1161/CIRCULATIONAHA.108.839282
  2. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-4. https://doi.org/10.1161/01.CIR.0000138929.71660.E0
  3. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. https://doi.org/10.1056/NEJMoa061254
  4. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-74. https://doi.org/10.1007/s00392-009-0101-6
  5. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281-92. https://doi.org/10.1016/j.jacc.2009.03.054
  6. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv 2008;72:950-7. https://doi.org/10.1002/ccd.21715
  7. Nakamura T, Brott BC, Brants I, et al. Vasomotor function after paclitaxel- coated balloon post-dilation in porcine coronary stent model. JACC Cardiovasc Interv 2011;4:247-55. https://doi.org/10.1016/j.jcin.2010.08.028
  8. Skalpe IO. The toxicity of non-ionic water-soluble monomeric and dimeric contrast media in selective vertebral angiography: an experimental study in rabbits. Neuroradiology 1983;24:219-23. https://doi.org/10.1007/BF00399775
  9. Limbruno U, Petronio AS, Amoroso G, et al. The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation 2000;101:491-7. https://doi.org/10.1161/01.CIR.101.5.491
  10. Sakata Y, Kodama K, Ishikura F, et al. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction. Jpn Circ J 1997;61: 455-8. https://doi.org/10.1253/jcj.61.455
  11. Iwakura K, Ito H, Okamura A, et al. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis. Circ J 2009;73:925-31. https://doi.org/10.1253/circj.CJ-08-1059
  12. Tsubokawa A, Ueda K, Sakamoto H, Iwase T, Tamaki S. Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy. Circ J 2002;66:1119-23. https://doi.org/10.1253/circj.66.1119